Rational pemetrexed combined with CIK therapy plus anti-PD-1 mAbs administration sequence will effectively promote the efficacy of CIK therapy in non-small cell lung cancer
Liu, SC; Meng, Y; Liu, L; Lv, YG; Wei, F; Yu, WW; Wang, LM; Zhang, XY; Ren, XB; Sun, Q
Ren, XB; Sun, Q (通讯作者)，Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc, Tianjin, Peoples R China.;Ren, XB; Sun, Q (通讯作者)，Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China.;Ren, XB; Sun, Q (通讯作者)，Tianjins Clin Res Ctr Canc, Tianjin, Peoples R China.;Ren, XB; Sun, Q (通讯作者)，Key Lab Canc Immunol & Biotherapy, Tianjin, Peoples R China.;Ren, XB; Sun, Q (通讯作者)，Tianjin Med Univ Canc Inst & Hosp, Dept Immunol, Tianjin, Peoples R China.;Ren, XB (通讯作者)，Tianjin Med Univ Canc Inst & Hosp, Dept Biotherapy, Tianjin, Peoples R China.
CANCER GENE THERAPY, 2023; 30 (2): 277
